FDA Amends Regulations for Investigational New Drug Applications and Clinical Holds

Summary

The Food and Drug Administration (FDA) published a direct final rule in the Federal Register on December 14, 1998, amending the regulations governing investigational new drug applications (INDs) for human drugs and biological products. The rule clarifies the agency's response to a sponsor's request to lift a clinical hold within 30 days.